Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2011-4-18
pubmed:abstractText
JAK2V617F mutation occurs in 90% of polycythemia vera (PV) and in 50% of essential thrombocythemia (ET) patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1594-0667
pubmed:author
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
17-21
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
JAK2V617F mutation is common in old patients with polycythemia vera and essential thrombocythemia.
pubmed:affiliation
Department of Medical and Surgical Sciences, University of Padova Medical School, Padova, Italy. marialuigia.randi@unipd.it
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't